Growth Factor‐Mediated Stabilization of Amyloid Precursor Protein mRNA Is Mediated by a Conserved 29‐Nucleotide Sequence in the 3′‐Untranslated Region
暂无分享,去创建一个
[1] C. Cahill,et al. Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences* , 1999, The Journal of Biological Chemistry.
[2] P. Reiner,et al. Regulation of Amyloid Precursor Protein Cleavage , 1999, Journal of neurochemistry.
[3] J. LaManna,et al. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. , 1998, Brain research. Molecular brain research.
[4] C. Moroni,et al. c‐jun N‐terminal kinase is involved in AUUUA‐mediated interleukin‐3 mRNA turnover in mast cells , 1998, The EMBO journal.
[5] A. Placzek,et al. Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40 , 1998, Brain Research.
[6] G. Brewer,et al. Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species. , 1998, Brain research. Molecular brain research.
[7] J. Malter,et al. hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA. , 1998, Nucleic acids research.
[8] M. Karin,et al. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. , 1998, Science.
[9] Douglas R. McDonald,et al. β-Amyloid Fibrils Activate Parallel Mitogen-Activated Protein Kinase Pathways in Microglia and THP1 Monocytes , 1998, The Journal of Neuroscience.
[10] L. Mucke,et al. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease , 1997, Nature.
[11] P. Gluckman,et al. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus. , 1997, Brain research. Molecular brain research.
[12] S. Murray,et al. Transcriptional and post‐transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: Effects of TGF‐β1 and serum deprivation , 1997, Journal of cellular biochemistry.
[13] R. Oliva,et al. Conserved elements in the 5′ regulatory region of the amyloid precursor protein gene in primates , 1997, Neuroscience Letters.
[14] S. Aschmies,et al. ADDITIVE EFFECTS OF BASIC FIBROBLAST GROWTH FACTOR AND PHORBOL ESTER ON β-AMYLOID PRECURSOR PROTEIN EXPRESSION AND SECRETION , 1997, Neurochemistry International.
[15] N. Perrone-Bizzozero,et al. The Elav-like Proteins Bind to a Conserved Regulatory Element in the 3′-Untranslated Region of GAP-43 mRNA* , 1997, The Journal of Biological Chemistry.
[16] L. Mucke,et al. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease , 1997, Brain Research Reviews.
[17] B. Winblad,et al. Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains. , 1996, Brain research. Molecular brain research.
[18] R. Beavis,et al. The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type , 1996, The Journal of Biological Chemistry.
[19] J. Malter,et al. Turnover and Translation of in Vitro Synthesized Messenger RNAs in Transfected, Normal Cells* , 1996, The Journal of Biological Chemistry.
[20] J. Sussenbach,et al. Growth-condition-dependent regulation of insulin-like growth factor II mRNA stability. , 1996, The Biochemical journal.
[21] Patrick L. McGeer,et al. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.
[22] K. Urakami,et al. Analysis of amyloid precursor protein mRNAs in skin fibroblasts in Down's syndrome. , 1996, Dementia.
[23] D. Premkumar,et al. Altered Expression of Amyloid β Precursor mRNAs in Cerebral Vessels, Meninges, and Choroid Plexus in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.
[24] S. Ng,et al. Aberrant GAP-43 gene expression in Alzheimer's disease. , 1995, The American journal of pathology.
[25] D. Graham,et al. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury , 1995, Nature Medicine.
[26] J. Malter,et al. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3'-untranslated region. , 1994, The Journal of biological chemistry.
[27] J. Malter,et al. Modulation of granulocyte-macrophage colony-stimulating factor mRNA stability in vitro by the adenosine-uridine binding factor. , 1994, The Journal of biological chemistry.
[28] D. Selkoe,et al. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Selkoe. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease , 1993, Trends in Neurosciences.
[30] Yaakov Stern,et al. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community‐dwelling elderly persons and their first‐degree relatives , 1993, Annals of neurology.
[31] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[32] K. Yoshikawa,et al. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor , 1992, Nature.
[33] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[34] D. Holtzman,et al. Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. , 1992, The EMBO journal.
[35] S. Deeb,et al. Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. , 1992, Biochemical and biophysical research communications.
[36] Y. Nagamine,et al. Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. Studies in vivo and in cell-free decay reactions. , 1991, The Journal of biological chemistry.
[37] N. Sato,et al. Cytokine messenger RNA stability is enhanced in tumor cells. , 1991, Blood.
[38] R. Wisdom,et al. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. , 1991, Genes & development.
[39] M. Goldberg,et al. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. , 1991, Blood.
[40] E. Stopa,et al. Basic fibroblast growth factor in Alzheimer's disease. , 1990, Biochemical and biophysical research communications.
[41] C. Finch,et al. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.
[42] K. Beyreuther,et al. Transgenic mice and Alzheimer's disease , 1990, Neurobiology of Aging.
[43] H. W. Harris,et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[44] W. Griffin,et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Ross,et al. Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component , 1989, Molecular and cellular biology.
[46] G. Sonenshein,et al. Serum deprivation of vascular smooth muscle cells enhances collagen gene expression. , 1988, The Journal of biological chemistry.
[47] R. Beavis,et al. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease. , 1996, The Journal of biological chemistry.
[48] C. Cotman,et al. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies , 1993 .
[49] D. Selkoe,et al. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. , 1993, Trends in neurosciences.
[50] C. Cotman,et al. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. , 1993, Neuroreport.
[51] D. Selkoe,et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.
[52] M. Greenberg,et al. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. , 1989, Genes & development.